Copyright Reports & Markets. All rights reserved.

Global Nuclear Receptor ROR-Gamma Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 VPR-66
        • 1.2.1.2 INV-17
        • 1.2.1.3 GSK-2981278
        • 1.2.1.4 BBI-6000
        • 1.2.1.5 Others
      • 1.2.2 by Application
        • 1.2.2.1 Hospital
        • 1.2.2.2 Clinic
        • 1.2.2.3 Others
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 VPR-66 Market, 2013-2018
      • 4.1.2 INV-17 Market, 2013-2018
      • 4.1.3 GSK-2981278 Market, 2013-2018
      • 4.1.4 BBI-6000 Market, 2013-2018
      • 4.1.5 Others Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 VPR-66 Market Forecast, 2019-2024
      • 4.2.2 INV-17 Market Forecast, 2019-2024
      • 4.2.3 GSK-2981278 Market Forecast, 2019-2024
      • 4.2.4 BBI-6000 Market Forecast, 2019-2024
      • 4.2.5 Others Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Hospital Market, 2013-2018
      • 5.1.2 Clinic Market, 2013-2018
      • 5.1.3 Others Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Hospital Market Forecast, 2019-2024
      • 5.2.2 Clinic Market Forecast, 2019-2024
      • 5.2.3 Others Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 4SC AG
    • 8.2 Advinus Therapeutics Ltd.
    • 8.3 Arrien Pharmaceuticals, LLC
    • 8.4 Aurigene Discovery Technologies Limited
    • 8.5 Biogen, Inc.
    • 8.6 Brickell Biotech, Inc.
    • 8.7 Bristol-Myers Squibb Company
    • 8.8 Celgene Corporation
    • 8.9 Genentech, Inc.
    • 8.10 Genfit SA
    • 8.11 GlaxoSmithKline Plc
    • 8.12 Hanmi Pharmaceuticals, Co. Ltd.
    • 8.13 Karo Bio AB
    • 8.14 Lead Pharma Holding B.V.
    • 8.15 Nuevolution AB
    • 8.16 Phenex Pharmaceuticals AG
    • 8.17 Reata Pharmaceuticals, Inc.
    • 8.18 Teijin Pharma Limited
    • 8.19 Visionary Pharmaceuticals, Inc.
    • 8.20 Vitae Pharmaceuticals, Inc.

    9 Conclusion

    Summary
    The global Nuclear Receptor ROR-Gamma market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    VPR-66
    INV-17
    GSK-2981278
    BBI-6000
    Others
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    4SC AG
    Advinus Therapeutics Ltd.
    Arrien Pharmaceuticals, LLC
    Aurigene Discovery Technologies Limited
    Biogen, Inc.
    Brickell Biotech, Inc.
    Bristol-Myers Squibb Company
    Celgene Corporation
    Genentech, Inc.
    Genfit SA
    GlaxoSmithKline Plc
    Hanmi Pharmaceuticals, Co. Ltd.
    Karo Bio AB
    Lead Pharma Holding B.V.
    Nuevolution AB
    Phenex Pharmaceuticals AG
    Reata Pharmaceuticals, Inc.
    Teijin Pharma Limited
    Visionary Pharmaceuticals, Inc.
    Vitae Pharmaceuticals, Inc.
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Hospital
    Clinic
    Others
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now